Lv1
50 积分 2025-11-27 加入
Multivalent linkers: A growing trend in antibody-drug conjugate development
5天前
已完结
Site-Specific Engineering of Chemical Functionalities on the Surface of Live Hepatitis D Virus
16天前
已完结
Dual-payload antibody–drug conjugates: Taking a dual shot
22天前
已完结
Site specific conjugation of ARX-788, an antibody drug conjugate (ADC) targeting HER2, generates a potent and stable targeted therapeutic for multiple cancers
1个月前
已关闭
In vitro selection of unnatural cyclic peptide libraries via mRNA display
2个月前
已完结
Modular Design and Self-assembly of pH-Responsive Multidomain Peptides Incorporating Non-natural Ionic Amino Acids
2个月前
已关闭
First-in-human, phase 1 dose escalation study of SL-279252, a hexameric PD1-Fc-OX40L fusion protein, in patients with advanced solid tumors and lymphoma
3个月前
已完结
The evolving landscape of 'next-generation' immune checkpoint inhibitors: A review
3个月前
已完结
Blocking OX-40/OX-40 Ligand Interaction In Vitro and In Vivo Leads to Decreased T Cell Function and Amelioration of Experimental Allergic Encephalomyelitis
4个月前
已完结
皖公网安备34019202002308
